Literature DB >> 9765497

Requirement for CD4(+) T cells in the Friend murine retrovirus neutralizing antibody response: evidence for functional T cells in genetic low-recovery mice.

H J Super1, D Brooks, K Hasenkrug, B Chesebro.   

Abstract

Recovery from infection with the Friend murine leukemia retrovirus complex (FV) requires T-helper cells and cytotoxic T cells as well as neutralizing antibodies. Several host genes, including genes of the major histocompatibility complex (H-2) and an H-2-unlinked gene, Rfv-3, influence these FV-specific immune responses. (B10.A x A/Wy)F1 mice, which have the H-2(a/a) Rfv-3(r/s) genotype, fail to mount a detectable FV-specific T-cell proliferative response but nevertheless produce FV-specific neutralizing immunoglobulin M (IgM) antibodies and can eliminate FV viremia. Thus, this IgM response, primarily influenced by the Rfv-3 gene, may be T-cell independent. To test this idea, mice were depleted of either CD4(+) or CD8(+) T-cell populations in vivo and were monitored for the effect on the neutralizing antibody response following FV infection. Surprisingly, mice in which CD4(+) cells were depleted showed undetectable FV-neutralizing antibody responses and high viremia levels compared to nondepleted or CD8-depleted animals. In addition to knocking out the FV antibody response, CD4(+) T-cell depletion reduced survival time significantly, further indicating the importance of CD4(+) T cells. These studies revealed the first evidence for a functional T-cell response following FV infection in these low-recovery mice and showed that CD4(+) T-helper cells are required for the Rfv-3-controlled FV antibody response.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9765497      PMCID: PMC110369     

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  28 in total

1.  Different H-2 subregions influence immunization against retrovirus and immunosuppression.

Authors:  R P Morrison; P L Earl; J Nishio; D L Lodmell; B Moss; B Chesebro
Journal:  Nature       Date:  1987 Oct 22-28       Impact factor: 49.962

Review 2.  Infections with herpes simplex viruses (1).

Authors:  L Corey; P G Spear
Journal:  N Engl J Med       Date:  1986-03-13       Impact factor: 91.245

3.  Therapy with monoclonal antibodies by elimination of T-cell subsets in vivo.

Authors:  S P Cobbold; A Jayasuriya; A Nash; T D Prospero; H Waldmann
Journal:  Nature       Date:  1984 Dec 6-12       Impact factor: 49.962

4.  CD4+ T cells are required to sustain CD8+ cytotoxic T-cell responses during chronic viral infection.

Authors:  M Matloubian; R J Concepcion; R Ahmed
Journal:  J Virol       Date:  1994-12       Impact factor: 5.103

5.  T-lymphocyte priming and protection against Friend leukemia by vaccinia-retrovirus env gene recombinant.

Authors:  P L Earl; B Moss; R P Morrison; K Wehrly; J Nishio; B Chesebro
Journal:  Science       Date:  1986-11-07       Impact factor: 47.728

6.  Use of monoclonal anti-gp70 antibodies to mimic the effects of the Rfv-3 gene in mice with Friend virus-induced leukemia.

Authors:  W J Britt; B Chesebro
Journal:  J Immunol       Date:  1983-05       Impact factor: 5.422

7.  Studies on the role of the host immune response in recovery from Friend virus leukemia. II. Cell-mediated immunity.

Authors:  B Chesebro; K Wehrly
Journal:  J Exp Med       Date:  1976-01-01       Impact factor: 14.307

8.  H-2D control of recovery from Friend virus leukemia: H-2D region influences the kinetics of the T lymphocyte response to Friend virus.

Authors:  W J Britt; B Chesebro
Journal:  J Exp Med       Date:  1983-06-01       Impact factor: 14.307

9.  Influence of the murine MHC (H-2) on Friend leukemia virus-induced immunosuppression.

Authors:  R P Morrison; J Nishio; B Chesebro
Journal:  J Exp Med       Date:  1986-02-01       Impact factor: 14.307

10.  Genetic control of T cell responsiveness to the Friend murine leukemia virus envelope antigen. Identification of class II loci of the H-2 as immune response genes.

Authors:  M Miyazawa; J Nishio; B Chesebro
Journal:  J Exp Med       Date:  1988-11-01       Impact factor: 14.307

View more
  9 in total

1.  Essential role for virus-neutralizing antibodies in sterilizing immunity against Friend retrovirus infection.

Authors:  Ronald J Messer; Ulf Dittmer; Karin E Peterson; Kim J Hasenkrug
Journal:  Proc Natl Acad Sci U S A       Date:  2004-08-05       Impact factor: 11.205

2.  Fine mapping of the friend retrovirus resistance gene, Rfv3, on mouse chromosome 15.

Authors:  H J Super; K J Hasenkrug; S Simmons; D M Brooks; R Konzek; K D Sarge; R I Morimoto; N A Jenkins; D J Gilbert; N G Copeland; W Frankel; B Chesebro
Journal:  J Virol       Date:  1999-09       Impact factor: 5.103

3.  Role of interleukin-4 (IL-4), IL-12, and gamma interferon in primary and vaccine-primed immune responses to Friend retrovirus infection.

Authors:  U Dittmer; K E Peterson; R Messer; I M Stromnes; B Race; K J Hasenkrug
Journal:  J Virol       Date:  2001-01       Impact factor: 5.103

4.  A Single Locus Controls Interferon Gamma-Independent Antiretroviral Neutralizing Antibody Responses.

Authors:  Melissa Kane; Felicity Deiss; Alexander Chervonsky; Tatyana V Golovkina
Journal:  J Virol       Date:  2018-07-31       Impact factor: 5.103

5.  Lymphocyte deficiencies increase susceptibility to friend virus-induced erythroleukemia in Fv-2 genetically resistant mice.

Authors:  K J Hasenkrug
Journal:  J Virol       Date:  1999-08       Impact factor: 5.103

Review 6.  Distinct roles of CD4+ T cell subpopulations in retroviral immunity: lessons from the Friend virus mouse model.

Authors:  Savita Nair; Wibke Bayer; Mickaël J Y Ploquin; George Kassiotis; Kim J Hasenkrug; Ulf Dittmer
Journal:  Retrovirology       Date:  2011-09-26       Impact factor: 4.602

Review 7.  Friend retrovirus studies reveal complex interactions between intrinsic, innate and adaptive immunity.

Authors:  Ulf Dittmer; Kathrin Sutter; George Kassiotis; Gennadiy Zelinskyy; Zoltán Bánki; Heribert Stoiber; Mario L Santiago; Kim J Hasenkrug
Journal:  FEMS Microbiol Rev       Date:  2019-09-01       Impact factor: 16.408

8.  Immunotherapy With Interferon α11, But Not Interferon Beta, Controls Persistent Retroviral Infection.

Authors:  Mara Schwerdtfeger; Julia Dickow; Yasmin Schmitz; Sandra Francois; Zehra Karakoese; Anna Malyshkina; Torben Knuschke; Ulf Dittmer; Kathrin Sutter
Journal:  Front Immunol       Date:  2022-01-20       Impact factor: 7.561

9.  Regulatory T cells suppress virus-specific antibody responses to Friend retrovirus infection.

Authors:  Tyler C Moore; Ronald J Messer; Kim J Hasenkrug
Journal:  PLoS One       Date:  2018-04-03       Impact factor: 3.240

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.